Maria Knapik-Kordecka
Overview
Explore the profile of Maria Knapik-Kordecka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zurawska-Plaksej E, Knapik-Kordecka M, Rorbach-Dolata A, Piwowar A
Arch Med Sci
. 2016 Oct;
12(5):977-984.
PMID: 27695487
Introduction: Chitotriosidase (CHIT1) is a chitinolytic enzyme involved mainly in the immune and inflammatory response. It shows increased activity in many pathologies, including in newly diagnosed type 2 diabetes (T2D)....
2.
Zurawska-Plaksej E, Lugowska A, Hetmanczyk K, Knapik-Kordecka M, Piwowar A
PLoS One
. 2015 Oct;
10(10):e0141730.
PMID: 26517273
Purpose: The pathophysiological role of human chitinases and chitinase-like proteins (CLPs) is not fully understood. We aimed to determine the levels of neutrophil-derived chitotriosidase (CHIT1), acidic mammalian chitinase (AMCase) and...
3.
Zurawska-Plaksej E, Kratz E, Ferens-Sieczkowska M, Knapik-Kordecka M, Piwowar A
Glycoconj J
. 2015 Oct;
33(1):29-39.
PMID: 26494371
Human blood plasma chitotriosidase (CHIT1) is a glycoprotein with chitinolytic activity with not fully elucidated biological function. Its increased level is observed in type 2 diabetes mellitus (T2DM) and is...
4.
Zurawska-Plaksej E, Lugowska A, Hetmanczyk K, Knapik-Kordecka M, Adamiec R, Piwowar A
Biomarkers
. 2014 Dec;
20(1):52-7.
PMID: 25519006
Objectives: To investigate chitotriosidase (CHIT1) activity and chitinase-3-like protein 1 (YKL-40) concentration in plasma of type 2 diabetic patients and evaluate their relationship with kidney dysfunction. Materials And Methods: 94...
5.
Zurawska-Plaksej E, Piwowar A, Knapik-Kordecka M, Warwas M
Arch Med Res
. 2013 Dec;
45(1):36-43.
PMID: 24316113
Background And Aims: Hyperglycemia and oxidative stress in type 2 diabetes (T2DM) provoke neutrophil overstimulation and the release and/or translocation of proteases from granules to the cell surface. Although the...
6.
Grzebyk E, Knapik-Kordecka M, Piwowar A
Pol Arch Med Wewn
. 2013 May;
123(7-8):364-70.
PMID: 23648800
Introduction: In type 2 diabetes, chronic hyperglycemia induces multi-faceted disturbances and contributes to late diabetic complications. Nonenzymatic glycation, leading to formation of advanced glycation end-products (AGEs), is one of the...
7.
Kordecki H, Knapik-Kordecka M, Karmowski M, Gworys B, Karmowski A
Adv Clin Exp Med
. 2013 Jan;
21(5):601-6.
PMID: 23356196
Background: Very often it is necessary to make a decision or to establish a diagnosis on the basis of great amounts of different kinds of data. In this paper the...
8.
Piwowar A, Knapik-Kordecka M, Warwas M
Clin Invest Med
. 2010 Apr;
33(2):E109.
PMID: 20370990
Purpose: Advanced oxidation protein products (AOPP) and ischemia-modified albumin (IMA) are forms of oxidatidatively modified albumin and have recently been investigated as indicators of oxidative stress. They are increased in...
9.
Zdrojowy K, Knapik-Kordecka M, Jakobsche-Policht U, Adamiec R
Pol Merkur Lekarski
. 2010 Feb;
27(162):458-62.
PMID: 20120706
Unlabelled: Proinflammatory cytokines play the crucial role in the arising and progression of atherosclerotic changes. Between them are: tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6). The significant role...
10.
Knapik-Kordecka M, Piwowar A, Zurawska-Plaksej E, Warwas M
Wiad Lek
. 2009 Mar;
61(10-12):263-8.
PMID: 19323066
Ischemia modified albumin (IMA) is a new biological marker for early identification of chest pain and ruling out myocardial infarction among patients with acute syndromes submitting to emergency department. Recently...